找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Resistant Hypertension; Massimo Salvetti Book 2016 Springer International Publishing Switzerland 2016 Difficult-to-treat hypertension.Fals

[復(fù)制鏈接]
樓主: 懇求
11#
發(fā)表于 2025-3-23 10:43:41 | 只看該作者
12#
發(fā)表于 2025-3-23 14:05:25 | 只看該作者
13#
發(fā)表于 2025-3-23 21:32:03 | 只看該作者
14#
發(fā)表于 2025-3-24 00:55:19 | 只看該作者
Adult Patient with Pseudo-Resistant Hypertension: Spurious Resistant Hypertension,ue resistance to treatment. In fact, studies have shown that up to one third of patients with suspected resistant hypertension have normal 24-h (or home) blood pressure values and that these patients have much less organ damage and a better prognosis as compared to “true resistant” hypertensives.
15#
發(fā)表于 2025-3-24 05:02:44 | 只看該作者
16#
發(fā)表于 2025-3-24 10:21:20 | 只看該作者
Adult Patient with Pseudo-Resistant Hypertension: High Blood Pressure Induced by Exogenous Substancfactors responsible for poor BP control. In these patients, after the assessment of adherence to lifestyle measures and to drug treatment, the diagnostic workup should include the evaluation of possible secondary forms of hypertension. An accurate evaluation of the drugs and substances assumed by th
17#
發(fā)表于 2025-3-24 12:51:17 | 只看該作者
18#
發(fā)表于 2025-3-24 16:35:13 | 只看該作者
Adult Patient with Pseudo-Resistant Hypertension: Drug Intolerance,ved. Today, several classes of effective antihypertensive drugs are available, and in particular ACE inhibitors, angiotensin II receptor blockers, calcium antagonists, diuretics and beta blockers are all considered first-line drugs by current European Guidelines; furthermore, other molecules may be
19#
發(fā)表于 2025-3-24 21:38:02 | 只看該作者
20#
發(fā)表于 2025-3-25 02:12:33 | 只看該作者
Adult Patient with Resistant Hypertension Secondary to Comorbidities,ic. Lifestyle was certainly not optimal in this obese patient. Obesity and overweight are quite common in patients with BP elevation, being present in about 75?% of the hypertensive patients seen by general practitioners or specialists. Together with combination treatment with antihypertensive drugs
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 21:02
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
沙洋县| 惠东县| 凌云县| 绥阳县| 凤城市| 沭阳县| 深州市| 镇康县| 宜昌市| 长岛县| 镇巴县| 和林格尔县| 库伦旗| 监利县| 阳曲县| 大悟县| 广元市| 读书| 卢湾区| 泸州市| 宝清县| 开鲁县| 无为县| 德昌县| 宽甸| 平阴县| 文昌市| 丰原市| 朔州市| 黄大仙区| 鄂托克前旗| 宁海县| 济阳县| 浮山县| 淮安市| 巴彦县| 明光市| 江华| 江油市| 巩义市| 新宁县|